US Stock MarketDetailed Quotes

GOSS Gossamer Bio

Watchlist
  • 0.9505
  • +0.0557+6.22%
Trading Apr 24 12:13 ET
215.97MMarket Cap-3.80P/E (TTM)

About Gossamer Bio Company

Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 26, 2015 and is headquartered in San Diego, CA.

Company Profile

SymbolGOSS
Company NameGossamer Bio
Listing DateFeb 8, 2019
Issue Price16.00
Founded2015
CEOMr. Faheem Hasnain
MarketNASDAQ
Employees145
Fiscal Year Ends12-31
Address3115 Merryfield Row,Suite 120
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-684-1300
Websitehttp://www.gossamerbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Faheem Hasnain
  • Chairman of the Board, President and Chief Executive Officer
  • 2.10M
  • Bob Smith
  • Chief Commercial Officer
  • 1.33M
  • Dr. Richard Aranda, M.D.
  • Chief Medical Officer
  • --
  • Bryan Giraudo
  • Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
  • 1.29M
  • Caryn Peterson
  • Executive Vice President, Regulatory Affairs
  • --
  • Christian Waage
  • Executive Vice President, Technical Operations and Administration
  • --
  • Skye Drynan
  • Independent Director
  • --
  • Russell J. Cox
  • Independent Director
  • 87.32K
  • Dr. Thomas O. Daniel, M.D.
  • Lead Independent Director
  • 98.82K
  • Dr. Steven Nathan, M.D.
  • Independent Director
  • --
  • Dr. Sandra Milligan, J.D.,M.D.
  • Independent Director
  • 81.82K
  • Dr. John D. Quisel, J.D.,PhD
  • Independent Director
  • 133.61K

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

No. Symbol Price
Sample Name
Sample Code
 5.675
Sample Name
Sample Code
 70.320
Sample Name
Sample Code
 235.480
4
Teradata Corp
TDC
21.405
5
Hutchmed (China)
HCM
15.609
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 262.570
Sample Name
Sample Code
 203.280
Sample Name
Sample Code
 136.220
4
Microsoft
MSFT
383.985
5
Vale SA
VALE
9.775
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 185.690
Sample Name
Sample Code
 262.540
Sample Name
Sample Code
 146.470
4
Netflix
NFLX
1092.440
5
Oracle
ORCL
136.210
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 9.970
Sample Name
Sample Code
 3.045
Sample Name
Sample Code
 2.950
4
Argo Blockchain
ARBK
0.4058
5
Hut 8
HUT
12.890
Unlock Now

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -